Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study

Nutrients. 2019 Sep 21;11(10):2269. doi: 10.3390/nu11102269.

Abstract

Favorable effects of a high-protein/moderate-carbohydrate (HP/MCHO) diet after weight loss on body weight management have been shown. To extend these findings, associations between perception of hunger and satiety with endocannabinoids, and with glucagon-like peptide-1 (GLP-1) and polypeptide YY (PYY) were assessed. At approximately 34 months after weight loss, 22 female and 16 male participants (mean age 64.5 ± 5.9 years; body mass index (BMI) 28.9 ± 3.9 kg/m2) completed a 48 h respiration chamber study. Participants were fed in energy balance with a HP/MCHO diet with 25%:45%:30% or a moderate-protein/high-carbohydrate (MP/HCHO) diet with 15%:55%:30% of energy from protein:carbohydrate:fat. Endocannabinoids and related compounds, relevant postprandial hormones (GLP-1, PYY), hunger, satiety, and ad libitum food intake were assessed. HP/MCHO versus MP/HCHO reduced hunger perception. The lower decremental area under the curve (dAUC) for hunger in the HP/MCHO diet (-56.6% compared to MP, p < 0.05) was associated with the higher AUC for 2-arachidonoylglycerol (2-AG) concentrations (p < 0.05). Hunger was inversely associated with PYY in the HP/MCHO group (r = -0.7, p < 0.01). Ad libitum food intake, homeostatic model assessment for insulin resistance (HOMA-IR) and incremental AUCs for gut peptides were not different between conditions. HP/MCHO versus MP/HCHO diet-induced reduction in hunger was present after 34 months weight maintenance in the post-obese state. HP/MCHO diet-induced decrease of hunger is suggested to interact with increased 2-AG and PYY concentrations.

Keywords: Protein; endocannabinoids; gut peptides; hunger; obesity; satiety; weight maintenance.

MeSH terms

  • Aged
  • Appetite / physiology
  • Arachidonic Acids / blood
  • Area Under Curve
  • Body Mass Index
  • Diet, High-Protein Low-Carbohydrate / methods*
  • Endocannabinoids / blood*
  • Energy Intake
  • Female
  • Glucagon-Like Peptide 1 / blood*
  • Glycerides / blood
  • Humans
  • Hunger / physiology
  • Insulin Resistance
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / diet therapy*
  • Peptide YY / blood*
  • Postprandial Period
  • Satiation / physiology
  • Weight Loss

Substances

  • Arachidonic Acids
  • Endocannabinoids
  • Glycerides
  • Peptide YY
  • Glucagon-Like Peptide 1
  • glyceryl 2-arachidonate